Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →21
🟡 Moderate
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
7,430
Total Claims
$488K
Drug Cost
1,127
Beneficiaries
$433
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 1,498 Interventional Pain Management providers
+46%
Opioid rate vs peers
67.2% vs 45.9% avg
-10%
Cost per patient vs peers
$433 vs $483 avg
+52%
Brand preference vs peers
6.3% vs 4.1% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
67.2%
Opioid Rate
4,995
Opioid Claims
$426K
Opioid Cost
21.0%
Long-Acting Rate
This provider's opioid prescribing rate of 67.2% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 465 claims · $267K
Generic: 6,965 claims · $221K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Buprenorphine Hcl | 107 | $80K |
| Oxycodone Hcl | 89 | $60K |
| Oxycodone Hcl/Acetaminophen | 1,599 | $51K |
| Buprenorphine | 125 | $43K |
| Oxycodone Myristate | 58 | $42K |
| Hydrocodone/Acetaminophen | 1,334 | $31K |
| Fentanyl | 160 | $18K |
| Oxymorphone Hcl | 21 | $17K |
| Hydrocodone Bitartrate | 23 | $16K |
| Tapentadol Hcl | 16 | $13K |
| Morphine Sulfate | 296 | $13K |
| Gabapentin | 667 | $12K |
| Buprenorphine | 11 | $11K |
| Oxycodone Hcl | 457 | $9,332 |
| Tapentadol Hcl | 12 | $8,539 |
Prescribing Profile
35
Unique Drugs
21.0
Anomaly Score
Patient Profile
70
Avg Age
68%
Female
1.76
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About